MariMed Inc. (MRMD)

Market Cap	148.50M
Revenue (ttm)	137.11M
Net Income (ttm)	8.62M
Shares Out	339.35M
EPS (ttm)	0.02
PE Ratio	17.90
Forward PE	23.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	157,089
Open	0.412
Previous Close	0.410
Day's Range	0.400 - 0.438
52-Week Range	0.280 - 0.770
Beta	3.02
Analysts	Strong Buy
Price Target	0.85 (+107.32%)
Earnings Date	May 8, 2023

About MRMD

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also l...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Jon R. Levine
• Employees: 592
• Stock Exchange: OTCMKTS
• Ticker Symbol: MRMD

Financial Performance

In 2022, MariMed's revenue was $134.01 million, an increase of 10.33% compared to the previous year's $121.46 million. Earnings were $13.47 million, an increase of 86.42%.

Analyst Forecast

According to one analyst, the rating for MRMD stock is "Strong Buy" and the 12-month stock price forecast is $0.85.

Price Target

$0.85

(107.32% upside)

Analyst Consensus: Strong Buy